Bone marrow suppression after chemoradiotherapy
Conditions
Interventions
Observation Group:In addition to standard treatment, the in-hospital preparation "Yisui Shengxue Pills" from Gansu Province was used (8 pills three times a day, orally).
Control Group:According to the guidelines, standardized radiotherapy and chemotherapy, as well as conventional Western medical supportive treatment for myelosuppression, have been completed.
Sponsors
Gansu Provincial Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Voluntary participation and written informed consent; 2. Age 18-80 years, regardless of gender; 3. Patients with a confirmed diagnosis of malignant tumor by histopathology or cytology; 4. Normal blood count, liver and kidney function, and electrocardiogram before radiotherapy/chemotherapy, with no symptoms of infection or fever; 5. Patients with indications for radiotherapy/chemotherapy and intended treatment; 6. Patients with no major organ damage and an estimated survival time of more than 3 months; 7. Patients with a KPS score = 70.
Exclusion criteria
Exclusion criteria: 1. Patients with underlying lung inflammation, or serious heart, liver, or kidney diseases, or those with severe infections; 2. Patients with mental illness or a history of severe mental illness; 3. Patients with myelodysplastic syndrome or primary hematologic disease; 4. Patients who have previously received other treatments similar to those in this study that may affect the observed outcomes; 5. Pregnant or breastfeeding women, or women who refuse contraception during the treatment observation period; 6. Patients with a history of severe allergies or specific physical conditions; 7. Patients with drug abuse or alcohol addiction; 8. Patients currently participating in other clinical trials; 9. Patients with allergies to the main ingredients of the investigational drug.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood Routine; | — |
Secondary
| Measure | Time frame |
|---|---|
| Erythropoietin;Thrombopoietin;Granulocyte colony-stimulating factor; | — |
Countries
China
Contacts
Public ContactHongtao Luo
Gansu Provincial Hospital of Traditional Chinese Medicine
Outcome results
None listed